Bryant AK, Sankar K, Strohbehn GW, Zhao L, et al. Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2022 Jan 31. pii: S0360-3016(22)00002.
PMID: 35115216